Xylem Inc. (XYL) Sets New 1-Year High at $51.85
Xylem Inc. (NYSE:XYL)’s share price reached a new 52-week high during trading on Wednesday . The company traded as high as $51.85 and last traded at $51.81, with a volume of 998,691 shares traded. The stock had previously closed at $50.74.
XYL has been the subject of a number of analyst reports. Royal Bank Of Canada raised shares of Xylem from a “sector perform” rating to an “outperform” rating and raised their price objective for the stock from $37.00 to $42.00 in a report on Wednesday, June 1st. Oppenheimer Holdings Inc. reiterated an “outperform” rating and set a $52.00 target price (up previously from $46.00) on shares of Xylem in a research report on Monday, June 20th. Zacks Investment Research cut shares of Xylem from a “buy” rating to a “hold” rating in a research report on Friday, July 15th. Barclays PLC increased their target price on shares of Xylem from $39.00 to $45.00 and gave the stock an “equal weight” rating in a research report on Monday, July 18th. Finally, RBC Capital Markets set a $51.00 target price on shares of Xylem and gave the stock a “buy” rating in a research report on Tuesday, August 16th. Nine research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $45.00.
The firm has a market cap of $9.28 billion, a P/E ratio of 27.66 and a beta of 1.15. The stock’s 50-day moving average is $49.85 and its 200 day moving average is $45.04.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/xylem-inc-xyl-sets-new-1-year-high-at-51-85.html
Xylem (NYSE:XYL) last announced its earnings results on Tuesday, August 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.47 by $0.01. The company earned $932 million during the quarter, compared to analysts’ expectations of $927.69 million. Xylem had a net margin of 9.22% and a return on equity of 16.41%. Xylem’s quarterly revenue was up 1.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.43 earnings per share. On average, equities research analysts expect that Xylem Inc. will post $2.04 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 21st. Investors of record on Wednesday, August 31st were given a dividend of $0.1549 per share. The ex-dividend date was Monday, August 29th. This represents a $0.62 annualized dividend and a yield of 1.20%. Xylem’s dividend payout ratio is 33.16%.
In related news, Director Steven R. Loranger sold 33,887 shares of the company’s stock in a transaction dated Thursday, August 11th. The shares were sold at an average price of $48.11, for a total transaction of $1,630,303.57. Following the completion of the sale, the director now owns 11,243 shares of the company’s stock, valued at $540,900.73. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Steven R. Loranger sold 32,246 shares of the company’s stock in a transaction dated Thursday, July 28th. The stock was sold at an average price of $48.01, for a total transaction of $1,548,130.46. Following the sale, the director now directly owns 38,334 shares of the company’s stock, valued at approximately $1,840,415.34. The disclosure for this sale can be found here. Corporate insiders own 0.77% of the company’s stock.
Large investors have recently bought and sold shares of the company. Renaissance Technologies LLC purchased a new stake in Xylem during the first quarter valued at $35,673,000. Legal & General Group Plc boosted its stake in Xylem by 1.8% in the first quarter. Legal & General Group Plc now owns 767,829 shares of the company’s stock valued at $31,403,000 after buying an additional 13,271 shares in the last quarter. Meeder Asset Management Inc. boosted its stake in Xylem by 45.9% in the first quarter. Meeder Asset Management Inc. now owns 25,240 shares of the company’s stock valued at $1,032,000 after buying an additional 7,938 shares in the last quarter. Geode Capital Management LLC boosted its stake in Xylem by 1.1% in the first quarter. Geode Capital Management LLC now owns 1,484,650 shares of the company’s stock valued at $60,604,000 after buying an additional 15,589 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. boosted its stake in Xylem by 362.8% in the first quarter. Adage Capital Partners GP L.L.C. now owns 1,240,920 shares of the company’s stock valued at $50,754,000 after buying an additional 972,803 shares in the last quarter. 84.69% of the stock is owned by institutional investors and hedge funds.
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Xylem Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.